Immunological characteristics of peripheral T cells as prognostic markers for Camrelizumab and Apatinib combination therapy in advanced squamous non-small-cell lung cancer.
第一作者:
Liangliang,Wu
第一单位:
Laboratory of Oncology, The First Medical Center of Chinese PLA General Hospital, Beijing, China; Institute of Oncology, Senior Department of Oncology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
作者:
主题词
人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms);女(雌)性(Female);男(雄)性(Male);中年人(Middle Aged);吡啶类(Pyridines);老年人(Aged);预后(Prognosis);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);免疫疗法(Immunotherapy);成年人(Adult);Th1细胞(Th1 Cells);T淋巴细胞(T-Lymphocytes)
DOI
10.1016/j.molimm.2025.01.011
PMID
39870014
发布时间
2025-02-10
- 浏览0
Molecular immunology
87-96页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文